ALMR — Alamar Biosciences, Inc.

ALMR closed at $30.39 (-0.98%) on Oct 26, 2026. Float: 35.3M shares. Latest SEC filing: 4 on Oct 23, 2026.

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Chart, dilution, float and news for ALMR in the TickerWise workspace.

Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.

Company profile

• Sector: Healthcare
• Industry: Biotechnology
• Country: US
• Exchange: NASDAQ
• Employees: 222

Latest SEC filings for ALMR

• 2026-10-234
• 2026-09-163
• 2026-09-033
• 2026-09-018-K
• 2026-08-1110-Q
• 2026-08-11SCHEDULE 13G
• 2026-08-108-K
• 2026-07-158-K
• 2026-05-0810-Q
• 2026-05-088-K

Latest ALMR news

• 2026-10-08Alamar: The Consumables Flywheel Is Just Getting Started Read article

Related companies

• VRTX — Vertex Pharmaceuticals Incorporated
• MRNA — Moderna, Inc.
• REGN — Regeneron Pharmaceuticals, Inc.
• ARGX — argenx SE
• ALNY — Alnylam Pharmaceuticals, Inc.
• INSM — Insmed Incorporated
• RVMD — Revolution Medicines, Inc.
• UTHR — United Therapeutics Corporation

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Educational tool only — not investment advice.